20 March 2017 (Monday) - Transfusion Evidence Alert email

The Transfusion evidence Alert game into my inbox this morning - loads of snippets today:

Latest Evidence in Transfusion Medicine

Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms
Roberts I, Edwards P, et al.,  Trials 2017

New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, Phase II ECLIPSE study
Taher AT, Origa R, et al. American Journal of Hematology 2017

Simulation training program for midwives to manage postpartum hemorrhage: a randomized controlled trial
Kato C, Kataoka Y. Nurse Education Today 2017

The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review
Bennett S, Baker LK, et al. HPB 2017

Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials
Li JF, Li H, et al. Journal of Orthopaedic Surgery and Research 2017

The effect of tranexamic acid in traumatic brain injury: a randomized controlled  trial
Jokar A, Ahmadi K, et al. Chinese Journal of Traumatology 2017

Role of prophylactic tranexamic acid in reducing blood loss during elective caesarean section: a randomized controlled study
Lakshmi SD, Abraham R. Journal of Clinical and Diagnostic Research. 2016.

Single-dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a randomized controlled trial
Holm C, Thomsen LL, et al. Vox Sanguinis 2017.

Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre study
Cancelas JA, Gottschall JL, et al. Vox Sanguinis 2017.

Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta-analysis
Chai-Adisaksopha C, Alexander PE, et al.  Vox Sanguinis 2017.